Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, par value of US$0.0001 per share
-
Shares outstanding
-
70,522,983
-
Total 13F shares
-
175,508
-
Share change
-
+167,918
-
Total reported value
-
$3,416,624
-
Price per share
-
$19.47
-
Number of holders
-
10
-
Value change
-
+$3,268,847
-
Number of buys
-
8
Institutional Holders of YD Bio Ltd - Ordinary Shares, par value of US$0.0001 per share (YDES) as of Q3 2025
As of 30 Sep 2025,
YD Bio Ltd - Ordinary Shares, par value of US$0.0001 per share (YDES) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
175,508 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, Cerity Partners LLC, HRT FINANCIAL LP, Cypress Capital Management LLC (WY), UBS Group AG, MORGAN STANLEY, Clear Street Group Inc., BNP PARIBAS FINANCIAL MARKETS, BARCLAYS PLC, and FMR LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.